Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

2024 ABPI Code update has launched – what’s next for pharma and QR codes? The long-anticipated update to the ABPI Code of ...

How the UK medical cannabis market is tackling supply chain strain ...

Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer.

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution ...

The genie is out of the bottle, folks – and we can’t put it back in. When Elon Musk’s people literally implanted a ‘brain-reading’ device into the brain of a human subject, it figuratively implanted ...

The unseemly public health blockage is a symptom of communal constipation that is not shifting. The distribution of pharmaceuticals through the traditional means is abjectly failing as a result. And ...

In many ways UK pharma and the life sciences are radical outliers – transcending politics and thriving irrespective of the sitting administration. Indeed, the pandemic was a case study in how the ...

According to an agreed principle, set in stone (quite literally) over 2000 years ago, I believe it is now 2024. Although what we know and what we believe are, of course, two very diferent things. The ...

As winter looms, so too does a name that sends chills through our collective soul – COVID-19. The pantomime baddie we hoped we’d seen the back of. In reality, COVID-19 does not represent the ...

The era of equity – or striving for it – is not about rewriting history. Nor is it about righting history’s myriad wrongs. History has happened. History is toast. History is, erm, history – in the ...